Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-146485

MELINTA THERAPEUTICS, INC. /NEW/ · MLNT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Mar 4, 2015
Accepted (ET)
Oct 20, 2016 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMar 4, 2015M15,000$13.10A15,392D
Common Stockholding———392D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F1$13.10Mar 4, 2015M15,000A—Jan 7, 2024Common Stock15,0000D
Stock Option (Right to Buy)F3,F2$7.62holding————Mar 19, 2022Common Stock15,00015,000D
Stock Option (Right to Buy)F3,F4$6.79holding————Feb 3, 2023Common Stock15,00015,000D
Stock Option (Right to Buy)F5$23.51holding————Dec 31, 2024Common Stock15,00015,000D
Stock Option (Right to Buy)F6$31.13holding————Dec 31, 2025Common Stock15,00015,000D

Explanation of responses